Table 1 Characteristics of 90 SRD patients given ECMO support
From: Outcomes of severe systemic rheumatic disease patients requiring extracorporeal membrane oxygenation
Variables | Value |
|---|---|
Women | 60 (66.7) |
Body mass index, kg/m2 | 26.3 ± 6.8 |
Age at ICU admission, years | 41.6 ± 15.2 |
Systemic rheumatic diseases | |
Diagnosis in the ICU | 31 (34.4) |
Diagnosis-to-ICU interval*, months | 93 (25–132) |
Connective tissue diseases | 52 (57.8) |
Systemic lupus erythematosus | 22 (24.4) |
Idiopathic inflammatory myositis | 12 (13.3) |
Antiphospholipid syndrome | 12 (13.3) |
Systemic sclerosis | 5 (5.6) |
Mixed connective tissue disease | 5 (5.6) |
Sjögren’s syndrome | 3 (3.3) |
Rheumatic disorders | 10 (11.1) |
Vasculitides | 10 (11.1) |
Goodpasture’s syndrome | 3 (3.3) |
ANCA-associated | 5 (5.6) |
Small-vessel | 1 (1.1) |
IgA-associated | 1 (1.1) |
Sarcoidosis | 5 (5.6) |
Nonmalignant eosinophilia-related diseases | 4 (4.4) |
Adult-onset Still’s disease | 4 (4.4) |
Others† | 5 (5.6) |
Pre-ICU Specific treatment(s) | |
Corticosteroids | 43 (47.8) |
Immunosuppressant(s)§ | 33 (36.7) |
Flare-related admission | 69 (76.7) |
Infection-related admission | 21 (23.3) |